LincRNA ZNF529-AS1 inhibits hepatocellular carcinoma via FBXO31 and predicts the prognosis of hepatocellular carcinoma patients
Abstract Background Invasion and metastasis of hepatocellular carcinoma (HCC) is still an important reason for poor prognosis. LincRNA ZNF529-AS1 is a recently identified tumour-associated molecule that is differentially expressed in a variety of tumours, but its role in HCC is still unclear. This s...
Main Authors: | Yang Ma, Wan-liang Sun, Shuo Shuo Ma, Guanru Zhao, Zhong Liu, Zheng Lu, Dengyong Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-02-01
|
Series: | BMC Bioinformatics |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12859-023-05189-0 |
Similar Items
-
Phenotypic Characteristics of the Tumour Microenvironment in Primary and Secondary Hepatocellular Carcinoma
by: Petros Fessas, et al.
Published: (2021-04-01) -
Targeting the Heterogeneous Tumour-Associated Macrophages in Hepatocellular Carcinoma
by: Aloña Agirre-Lizaso, et al.
Published: (2023-10-01) -
Limitations and Possibilities of Transarterial Chemotherapeutic Treatment of Hepatocellular Carcinoma
by: Charlotte Ebeling Barbier, et al.
Published: (2021-12-01) -
Comparable Overall Survival in Patients with Hepatocellular Carcinoma Diagnosed within and outside a Surveillance Programme: The Potential Impact of Liver Cirrhosis
by: Rosemary E. Faulkes, et al.
Published: (2023-02-01) -
An angiogenesis-related three-long non-coding ribonucleic acid signature predicts the immune landscape and prognosis in hepatocellular carcinoma
by: Wenjuan Wang, et al.
Published: (2023-03-01)